There are many reports that octreotide acetate(SMS)is effective for terminally ill cancer patients with malignant bowel obstructions such as nausea, vomiting and abdominal distension. We retrospectively found that the clinical efficacy of SMS in 23 patients with these symptoms depended on the early terminal stage(about six months until death)or middle terminal stage(within one month until death). SMS was more effective to relieve abdominal distension(p=0. 01)and these bowel symptoms occurred among cancer patients in the early terminal stage rather than in the middle terminal stage(p<0. 001).
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
cancer patients
12
patients malignant
8
malignant bowel
8
bowel symptoms
8
early terminal
8
middle terminal
8
terminal
5
[clinical efficacy
4
efficacy octreotide
4
octreotide acetate
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!